HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Comparison between hemolysis percentage measurement and hemiglobincyanide measurement for standardizing the evaluation of hemolytic properties of biomaterials].

Abstract
In this study, two methods--the supernatant hemoglobin spectrophotometry, i.e. hemolysis percentage measurement(according to ISO/TR 7405) and the hemiglobincyanide measurement(according to ISO 10993-4)--were used to assay the hemolytic properties of hydroxyapatite(bioceramics) and collagen (polymer). The results showed that the conclusions drawn from using the two methods were basically consistent, and the latter was more sensitive, stable and comparable. However, some of the procedures in the hemiglobincyanide method were not defined in details. So based on our experiments we have offered some suggestions and improvements, which do not deviate from ISO and ASTM standards, for hiher practicability of usig it in standardizing the evaluation of the hemolytic properties of biomaterials. Hemiglobincyanide measurement is worthy of wider application.
AuthorsLingli Zhang, Weijing Zhu, Yanfei Tan, Shuxin Qu, Xingdong Zhang
JournalSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi (Sheng Wu Yi Xue Gong Cheng Xue Za Zhi) Vol. 21 Issue 1 Pg. 111-4, 137 (Feb 2004) ISSN: 1001-5515 [Print] China
PMID15022478 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Hemoglobins
  • hemiglobincyanide
  • Collagen
  • Methemoglobin
  • Durapatite
Topics
  • Animals
  • Collagen
  • Durapatite
  • Hemoglobins
  • Hemolysis
  • Humans
  • Materials Testing (methods)
  • Methemoglobin (analogs & derivatives)
  • Rabbits

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: